WO2007012841A3 - Compositions comprising monobutyrin - Google Patents
Compositions comprising monobutyrin Download PDFInfo
- Publication number
- WO2007012841A3 WO2007012841A3 PCT/GB2006/002778 GB2006002778W WO2007012841A3 WO 2007012841 A3 WO2007012841 A3 WO 2007012841A3 GB 2006002778 W GB2006002778 W GB 2006002778W WO 2007012841 A3 WO2007012841 A3 WO 2007012841A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- monobutyrin
- compositions
- regeneration
- promoting
- musculo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to compositions/medicaments, devices and methods for treating musculo-skeletal tissue. The pharmaceutical composition for promoting musculo-skeletal tissue repair, regeneration and/or formation comprises monobutyrin and/or derivatives, fragments and/or analogues thereof, and a second agent capable of promoting musculoskeletal tissue repair, regeneration and/or formation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0515477.8 | 2005-07-28 | ||
GBGB0515477.8A GB0515477D0 (en) | 2005-07-28 | 2005-07-28 | Composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007012841A2 WO2007012841A2 (en) | 2007-02-01 |
WO2007012841A3 true WO2007012841A3 (en) | 2007-08-16 |
Family
ID=34976736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/002778 WO2007012841A2 (en) | 2005-07-28 | 2006-07-25 | Compositions comprising monobutyrin |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0515477D0 (en) |
WO (1) | WO2007012841A2 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137734A (en) * | 1989-03-22 | 1992-08-11 | Dana Farber Cancer Institute | Angiogenic monoglycerides |
WO2002100426A1 (en) * | 2001-06-08 | 2002-12-19 | Smith & Nephew Plc | Bmp binding proteins for use in bone or cartilage regeneration |
US20030055511A1 (en) * | 2000-03-03 | 2003-03-20 | Schryver Jeffrey E. | Shaped particle comprised of bone material and method of making the particle |
WO2005025634A2 (en) * | 2003-05-21 | 2005-03-24 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
-
2005
- 2005-07-28 GB GBGB0515477.8A patent/GB0515477D0/en not_active Ceased
-
2006
- 2006-07-25 WO PCT/GB2006/002778 patent/WO2007012841A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137734A (en) * | 1989-03-22 | 1992-08-11 | Dana Farber Cancer Institute | Angiogenic monoglycerides |
US20030055511A1 (en) * | 2000-03-03 | 2003-03-20 | Schryver Jeffrey E. | Shaped particle comprised of bone material and method of making the particle |
WO2002100426A1 (en) * | 2001-06-08 | 2002-12-19 | Smith & Nephew Plc | Bmp binding proteins for use in bone or cartilage regeneration |
WO2005025634A2 (en) * | 2003-05-21 | 2005-03-24 | Dexcom, Inc. | Biointerface membranes incorporating bioactive agents |
Non-Patent Citations (1)
Title |
---|
BUDAVARI S ED - MARYADELE J O'NEIL ET AL: "The Merck index, Thirteenth Edition, Monograph No 1322", MERCK INDEX. AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS, WHITEHOUSE STATION, NJ : MERCK & CO, US, 2001, pages 223, XP002424775, ISBN: 0-911910-13-1 * |
Also Published As
Publication number | Publication date |
---|---|
GB0515477D0 (en) | 2005-08-31 |
WO2007012841A2 (en) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006125539A3 (en) | Combination therapy comprising diaryl ureas for treating diseases | |
WO2006121861A3 (en) | Biphenylazetidinone cholesterol absorption inhibitors | |
WO2007027527A3 (en) | Isoindole-imide compounds and compositions comprising and methods of using the same | |
WO2008024439A3 (en) | 4-aminoquinazoline derivatives and methods of use thereof | |
TWI369987B (en) | New pharmaceutical compositions for the treatment of hyper-proliferative disorders | |
WO2007106537A3 (en) | Aminoquinolones as gsk-3 inhibitors | |
WO2006086562A3 (en) | Phenylazetidinone derivatives | |
AU2005339139A8 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
WO2006124748A3 (en) | Multicyclic compounds and methods of their use | |
WO2005086656A3 (en) | Heteroarylaminopyrazole derivatives useful for the treatment of diabetes | |
WO2006102674A3 (en) | Diphenylheterocycle cholesterol absorption inhibitors | |
WO2007084424A3 (en) | Treatment of substance abuse | |
WO2007064931A3 (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
WO2010127099A3 (en) | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
ZA200806778B (en) | N-Hydroxyacrylamide compounds | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
WO2007056142A3 (en) | Methods of preventing the serotonin syndrome and compositions for use therefor | |
WO2007121088A3 (en) | Combinations of therapeutic agents for treating cancer | |
WO2004113297A3 (en) | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | |
WO2009035634A3 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors | |
WO2008008700A3 (en) | Substituted cyclopentane derivatives as therapeutic agents | |
WO2007123740A3 (en) | Pharmaceutical compositions for promoting wound healing | |
WO2004009091A8 (en) | Purine derivatives as liver x receptor agonists | |
WO2006113718A3 (en) | Compositions for the treatment of neoplasms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06765102 Country of ref document: EP Kind code of ref document: A2 |